Stocktoria
Allarity Therapeutics, Inc. ALLR
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-12-21
Allarity Therapeutics, Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $320,000 | $0 | — | — | — | — |
| Gross profit | — | — | — | -$2.3M | — | — |
| R&D expense | $6.6M | $6.1M | $7.1M | $6.9M | $14.2M | $4.2M |
| Operating income | -$12.6M | -$27.2M | -$17.1M | -$34.5M | -$26.6M | -$8.3M |
| Interest expense | — | — | $498,000 | $223,000 | — | $93,000 |
| Income tax | $0 | -$381,000 | $83,000 | -$1.5M | $133,000 | $198,000 |
| Net income | -$11.2M | -$24.5M | -$11.9M | -$16.1M | -$26.6M | -$6.6M |
| EPS (diluted) | — | — | $-10.26 | $-3093.42 | $-4.19 | — |
| Operating cash flow | -$14.8M | -$17.4M | -$12.7M | -$16.8M | -$14.9M | -$7.3M |
| Free cash flow | -$14.8M | -$17.6M | -$12.7M | -$16.8M | — | -$7.3M |
| Cash & equivalents | $14.7M | $19.5M | $166,000 | $2.0M | — | $298,000 |
| Total assets | $18.3M | $22.6M | $11.9M | $14.5M | $49.6M | $33.4M |
| Total liabilities | $8.4M | $10.8M | $14.6M | $12.7M | $30.8M | $9.0M |
| Shareholders' equity | $9.8M | $11.8M | -$2.8M | -$113,000 | $18.2M | $26.9M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.